Analyses of APP/IR‐dKI, whose cognitive signature could simulate that of AD patients with T2DM, suggest that AD exacerbation by insulin resistance is mediated by impaired nAChRα7. This evidence concerns the gene CHRNA7 and Alzheimer disease.